 |
Tetrabenazine |
|---|---|
| Trade Name | Xenazine |
| Orphan Indication | Huntington disease |
| USA Market Approval | USA |
| USA Designation Date | 1997-12-11 00:00:00 |
| Sponsor | Prestwick Pharmaceuticals, Inc;1825 K Street NW, Suite 1475;Washington, District of Columbia, 20006 |
Related Access Program